Atenolol Market revenue to cross USD 28 Billion by 2035, says Research Nester
22 août 2023 07h56 HE
|
Research Nester
New York, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Atenolol Market size is expected to expand at ~ 5% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD 28 billion by...
Inotropic Agents Market Value to Surpass US$ 5.1 Bn by 2031: TMR Study
07 mars 2023 14h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...
Worldwide Diltiazem Industry to 2028 - Increase in Cardiovascular Disease Incidence is Driving Growth
21 oct. 2021 06h58 HE
|
Research and Markets
Dublin, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Capsules, Injection, and Tablets); Application (Angina,...
Outlook on the Global Refractory Angina Industry to 2030 - 11-Year Forecast of Refractory Angina Epidemiology
09 sept. 2020 06h53 HE
|
Research and Markets
Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Refractory Angina (RA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina
31 janv. 2020 09h00 HE
|
Neovasc, Inc.
Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or...
Cardiology Care Leaders Unite to Educate Over 1,000 Physicians on Diagnostic Protocols and Treatment Strategies At CardioCareLive
13 févr. 2013 13h26 HE
|
PlatformQ, the Leader in Live Online Events
NEEDHAM, Mass., Feb. 13, 2013 (GLOBE NEWSWIRE) -- CardioCareLive, the website for live interactive video cardiology conferences, today announced that more than 1,000 clinicians attended the Johns...